BioSpace News Archive

Theragun LLC, the leader in percussive massage therapy, announced today that it has filed separate patent infringement lawsuits in the state of California against manufacturers and sellers of massage devices to protect their percussive massage intellectual property.

Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company developing innovative technologies for the early diagnosis of cancers, today announced the additions of three renowned medical doctors to its Hepatology Board.

GrowGeneration Corp. (OTCQX: GRWG), (“GrowGen” or the “Company”) the largest chain of specialty hydroponic and organic garden centers, with currently 23 locations, today reported financial results for its quarter ended June 30, 2019.

Confirm BioSciences, a leading developer of high-quality diagnostic testing and health and wellness solutions, today announced the addition of two key executive appointments to its global sales team, bringing to the group vast expertise across both strategic and enterprise sales in the diagnostics, drug testing and workplace screening sectors.

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best in class bioproduction tools for cell and gene therapies, today announced that it has executed a share exchange agreement to effect the acquisition of SAVSU Technologies, a leading developer of advanced cold chain management tools for cell and gene therapies.

NextFlex®, America’s Flexible Hybrid Electronics (FHE) Manufacturing Institute, today announced that its Technology Hub’s fabrication facility in San Jose now complies with FDA manufacturing standards for medical devices.

Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has received approval from the U.S. government and successfully imported an initial shipment of medical cannabinoids into the U.S. to support two clinical trials led by NYU School of Medicine.

Meitheal Pharmaceuticals (“Meitheal”), a fully integrated generic injectables company based in Chicago, Illinois today announced that Hong Kong King-Friend Industrial Company, a wholly-owned subsidiary of China-based manufacturer Nanjing King-Friend Biochemical Pharmaceutical Company (NKF), has agreed to take an increased stake in the business for US$95 million

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today reported financial results for the second quarter ended June 30, 2019.

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, today reported financial results for the second quarter ended June 30, 2019